Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma

Philippe Moreau; Niels W. C. J. van de Donk; Jesus San Miguel; Henk Lokhorst; Hareth Nahi; Dina Ben-Yehuda; Michele Cavo; Gordon Cook; Michel Delforge; Hermann Einsele; Sonja Zweegman; Heinz Ludwig; Christoph Driessen; Antonio Palumbo; Thierry Facon; Torben Plesner; Meletios Dimopoulos; Pia Sondergeld; Pieter Sonneveld; Maria-Victoria Mateos

doi:https://doi.org/10.1007/s40265-016-0573-4

Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma

Philippe Moreau, Niels W. C. J. van de Donk, Jesus San Miguel, Henk Lokhorst, Hareth Nahi, Dina Ben-Yehuda, Michele Cavo, Gordon Cook, Michel Delforge, Hermann Einsele, Sonja Zweegman, Heinz Ludwig, Christoph Driessen, Antonio Palumbo, Thierry Facon, Torben Plesner, Meletios Dimopoulos, Pia Sondergeld, Pieter Sonneveld, Maria-Victoria Mateos

Hematology (VUmc)

Research output: Contribution to journal › Article › Academic › peer-review

36 Citations (Scopus)

Original language	English
Pages (from-to)	853-867
Journal	Drugs
Volume	76
Issue number	8
DOIs	https://doi.org/10.1007/s40265-016-0573-4
Publication status	Published - May 2016

Access to Document

https://doi.org/10.1007/s40265-016-0573-4

Cite this

Moreau, P., van de Donk, N. W. C. J., Miguel, J. S., Lokhorst, H., Nahi, H., Ben-Yehuda, D., Cavo, M., Cook, G., Delforge, M., Einsele, H., Zweegman, S., Ludwig, H., Driessen, C., Palumbo, A., Facon, T., Plesner, T., Dimopoulos, M., Sondergeld, P., Sonneveld, P., & Mateos, M.-V. (2016). Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma. Drugs, 76(8), 853-867. https://doi.org/10.1007/s40265-016-0573-4

@article{94187abc3e7d48e683d9eb8a12e8820e,

title = "Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma",

author = "Philippe Moreau and {van de Donk}, {Niels W. C. J.} and Miguel, {Jesus San} and Henk Lokhorst and Hareth Nahi and Dina Ben-Yehuda and Michele Cavo and Gordon Cook and Michel Delforge and Hermann Einsele and Sonja Zweegman and Heinz Ludwig and Christoph Driessen and Antonio Palumbo and Thierry Facon and Torben Plesner and Meletios Dimopoulos and Pia Sondergeld and Pieter Sonneveld and Maria-Victoria Mateos",

year = "2016",

month = may,

doi = "https://doi.org/10.1007/s40265-016-0573-4",

language = "English",

volume = "76",

pages = "853--867",

journal = "Drugs",

issn = "0012-6667",

publisher = "Adis International Ltd",

number = "8",

}

Moreau, P, van de Donk, NWCJ, Miguel, JS, Lokhorst, H, Nahi, H, Ben-Yehuda, D, Cavo, M, Cook, G, Delforge, M, Einsele, H, Zweegman, S, Ludwig, H, Driessen, C, Palumbo, A, Facon, T, Plesner, T, Dimopoulos, M, Sondergeld, P, Sonneveld, P & Mateos, M-V 2016, 'Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma', Drugs, vol. 76, no. 8, pp. 853-867. https://doi.org/10.1007/s40265-016-0573-4

TY - JOUR

T1 - Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma

AU - Moreau, Philippe

AU - van de Donk, Niels W. C. J.

AU - Miguel, Jesus San

AU - Lokhorst, Henk

AU - Nahi, Hareth

AU - Ben-Yehuda, Dina

AU - Cavo, Michele

AU - Cook, Gordon

AU - Delforge, Michel

AU - Einsele, Hermann

AU - Zweegman, Sonja

AU - Ludwig, Heinz

AU - Driessen, Christoph

AU - Palumbo, Antonio

AU - Facon, Thierry

AU - Plesner, Torben

AU - Dimopoulos, Meletios

AU - Sondergeld, Pia

AU - Sonneveld, Pieter

AU - Mateos, Maria-Victoria

PY - 2016/5

Y1 - 2016/5

U2 - https://doi.org/10.1007/s40265-016-0573-4

DO - https://doi.org/10.1007/s40265-016-0573-4

M3 - Article

C2 - 27113582

SN - 0012-6667

VL - 76

SP - 853

EP - 867

JO - Drugs

JF - Drugs

IS - 8

ER -